Depression and posttraumatic stress disorder among hiv-infected gambians on antiretroviral therapy

AIDS Patient Care and STDs

Volumn 26, Issue 10, 2012, Pages 589-596

  Peterson, Kevin ^a   Togun, Toyin ^b   Klis, Sandor ^c   Menten, Joris ^a   Colebunders, Robert ^a,d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; FEMALE; FOLLOW UP; GAMBIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPACT OF EVENTS SCALE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; TREATMENT DURATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DEPRESSION; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAMBIA; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; STRESS DISORDERS, POST-TRAUMATIC; VIRAL LOAD; YOUNG ADULT;

EID: 84866988681     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0089     Document Type: Article

References (48)

1. Vranceanu AM, Safren SA, Lu M, et al. The relationship of post-traumatic stress disorder and depression to anti-retroviral medication adherence in persons with HIV. AIDS Patient Care STDs 2008;22:313-321. (Pubitemid 351562964)
2. Breslau N. Depressive symptoms, major depression, and generalized anxiety: A comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res 1985;15:219-229. (Pubitemid 15042334)
3. + 0counts in people living with HIV. AIDS Patient Care STDs 2005;19:728-736. (Pubitemid 41705169)
4. Aromeh E, Akpenna D, Okeke M, et al. Structured treatment preparation as an intervention to alleviate depressive, anxiety and stress symptoms in HIV+ patients commencing ART. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Abstract TUPE 214. Rome, Italy: International AIDS Society; July 17-20, 2011.
5. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539-545.
6. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm 2000;57:376-386; quiz 387-379.
7. Kekwaletswe C, Morojele N, Nkosi S. Depression, alcohol use and adherence to antiretroviral therapy (ART). 6th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Abstract MOPE 189. Rome, Italy: International AIDS Society; July 17-20, 2011.
8. Hartzell JD, Janke IE, Weintrob AC. Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother 2008;62:246-255. (Pubitemid 351984767)
9. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007;21:1175-1183. (Pubitemid 46763288)
10. Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: S longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr 2010;53:266-272.
11. Nakimuli-Mpungu E, Musisi S, Katabira E, Nachega J, Bass J. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda. J Affect Disord 2011;135:160-167.
12. Kapetanovic S, Wiegand RE, Dominguez K, et al. Associations of medically documented psychiatric diagnoses and risky health behaviors in highly active antiretroviral therapy-experienced perinatally HIV-infected youth. AIDS Patient Care STDs 2011;25:493-501.
13. Wanke C. Pathogenesis and consequences of HIV-associated wasting. J Acquir Immune Defic Syndr 2004;37(Suppl 5):S277-279. (Pubitemid 39602329)
14. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: Prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs 2008;22:147-158. (Pubitemid 351252588)
15. Kumar V, Encinosa W. Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients. Psychiatr Q 2009;80:131-141.
16. Walkup J, Wei W, Sambamoorthi U, Crystal S. Anti-depressant treatment and adherence to combination anti-retroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008;79:43-53.
17. Sherr L, Nagra N, Kulubya G, Catalan J, Clucas C, Harding R. HIV infection associated post-traumatic stress disorder and post-traumatic growth\A systematic review. Psychol Health Med 2011;16:612-629.
18. Beckerman NL, Auerbach C. Post-traumatic stress disorder and HIV: A snapshot of co-occurrence. Soc Work Health Care 2010;49:687-702.
19. Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2007(3):CD003388.
20. Gibson K, Rueda S, Rourke SB, et al. Mastery and coping moderate the negative effect of acute and chronic stressors on mental health-related quality of life in HIV. AIDS Patient Care STDs 2011;25:371-381.
21. Lyketsos CG, Hoover DR, Guccione M, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996;153:1430-1437. (Pubitemid 26365457)
22. Leserman J, Pence BW, Whetten K, et al. Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry 2007;164:1707-1713. (Pubitemid 350205348)
23. Sheriff RJ, Adams CE, Tharyan P, Jayaram M, Duley L. Randomised trials relevant to mental health conducted in low and middle-income countries: A survey. BMC Psychiatry. 2008;8:69.
24. Olley BO, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: A 6-month follow-up study. J Psychosom Res 2006;61:479-484. (Pubitemid 44441442)
25. Kaharuza FM, Bunnell R, Moss S, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav 2006;10(4 Suppl):S105-111.
26. Klis S, Velding K, Gidron Y, Peterson K. Posttraumatic stress and depressive symptoms among people living with HIV in the Gambia. AIDS Care 2011;23:426-434.
27. Monahan PO, Shacham E, Reece M, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med 2009;24:189-197.
28. Igie T, Udoh M. Prevalence of depression in HIV/AIDS patients, Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Abstract CDB 232. Rome, Italy: International AIDS Society; July 17-20, 2011.
29. Celano CM, Freudenreich O, Fernandez-Robles C, Stern TA, Caro MA, Huffman JC. Depressogenic effects of medications: a review. Dialogues Clin Neurosci 2011;13: 109-125.
30. Cohen MH, Fabri M, Cai X, et al. Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women. J Womens Health (Larchmt) 2009;18:1783-1791.
31. Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav 2006;10:253-261.
32. Judd FK, Cockram AM, Komiti A, Mijch AM, Hoy J, Bell R. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study. Aust N Z J Psychiatry 2000;34:1015-1021.
33. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry 2003;54:307-316. (Pubitemid 37267860)
34. Peterson I, Togun O, De Silva T, et al. Mortality and Im-muno-virological outcomes on antiretroviral therapy in HIV-1 and HIV-2 infected individuals in the Gambia, West Africa. AIDS (in press).
35. Fincham D, Smit J, Carey P, Stein DJ, Seedat S. The relationship between behavioural inhibition, anxiety disorders, depression and CD4 counts in HIV-positive adults: A cross-sectional controlled study. AIDS Care 2008;20:1279-1283.
36. Martin L, Kagee A. Lifetime and HIV-related PTSD among persons recently diagnosed with HIV. AIDS Behav 2011;15:125-131.
37. Kagee A. Symptoms of distress and posttraumatic stress among South African former political detainees. Ethn Health 2005;10:169-179. (Pubitemid 40516807)
38. Schneider G. Antiretroviral Therapy: A Manual for Health Workers. 2004.
39. Gonzalez A, Zvolensky MJ, Parent J, Grover KW, Hickey M. HIV symptom distress and anxiety sensitivity in relation to panic, social anxiety, and depression symptoms among HIV-positive adults. AIDS Patient Care STDs 2012;26:156-164.
40. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993;270:2568-2573. (Pubitemid 23346695)
41. Yamazaki S, Fukuhara S, Green J. Usefulness of five-item and three-item Mental Health Inventories to screen for depressive symptoms in the general population of Japan. Health Qual Life Outcomes 2005;3:48.
42. Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010;8:348-353.
43. Thoresen S, Tambs K, Hussain A, Heir T, Johansen VA, Bisson JI. Brief measure of posttraumatic stress reactions: Impact of Event Scale-6. Soc Psychiatry Psychiatr Epidemiol 2010;45:405-412.
44. Cuijpers P, Smits N, Donker T, ten Have M, de Graaf R. Screening for mood and anxiety disorders with the five-item, the three-item, and the two-item Mental Health Inventory. Psychiatry Res 2009;168:250-255.
45. Patel V, Araya R, Chatterjee S, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 2007;370:991-1005. (Pubitemid 47384829)
46. Olley BO. Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: A controlled outcome study. AIDS Care 2006;18:1025-1031. (Pubitemid 44521860)
47. Schaal S, Elbert T, Neuner F. Narrative exposure therapy versus interpersonal psychotherapy. A pilot randomized controlled trial with Rwandan genocide orphans. Psy-chother Psychosom 2009;78:298-306.
48. Ertl V, Pfeiffer A, Schauer E, Elbert T, Neuner F. Community-implemented trauma therapy for former child soldiers in Northern Uganda: A randomized controlled trial. JAMA 2011;306:503-512.